Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths
Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths
WASHINGTON (AP) — Drugmaker Sarepta Therapeutics (SRPT) said late Friday it won't comply with a request from the Food and Drug Administration to halt all shipments of its gene th...
ImCheck’s ICT01 Earns FDA Orphan Drug Designation for AML
ImCheck’s ICT01 Earns FDA Orphan Drug Designation for AML
ImCheck's ICT01 gains an orphan drug designation from the FDA, offering hope for acute myeloid leukemia (AML) treatment in older patients with limited options. Phase 1 trials showed ICT01&...
FDA Announces Major Recall of Popular Deodorant
FDA Announces Major Recall of Popular Deodorant
Important to stay informed about recalls, because doing so truly impacts your life. Of course, the sooner you know about a recall, the better, because you can make sure to get rid of the suspecting it...
FDA fast tracks one-time intravitreal gene therapy for geographic atrophy
FDA fast tracks one-time intravitreal gene therapy for geographic atrophy
SAR446597 is designed to inhibit C1s and factor Bb in the complement pathway. Fast track designation expedites the development and review of treatments.
FDA Votes Against Proposed
FDA Votes Against Proposed
FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma
UC San Diego Expands Its Capacity
UC San Diego Expands Its Capacity
UC San Diego Expands Its Capacity to Test Innovative Treatments for Disease
Simvastatin Does Not Enhance Escitalopram
Simvastatin Does Not Enhance Escitalopram
Data Show Simvastatin Does Not Enhance Escitalopram Response in Comorbid Depression and Obesity
MAIA Biotechnology
MAIA Biotechnology
MAIA Biotechnology publishes preclinical data on cancer drug candidates
Zanubrutinib Outperforms Acalabrutinib in Adjusted Head-to-Head Analysis
Zanubrutinib Outperforms Acalabrutinib in Adjusted Head-to-Head Analysis
An adjusted analysis of the ALPINE and ASCEND trials revealed a statistically significant progression-free survival advantage for Zanubrutinib.
FDA Announces Plan to Phase Out Animal Testing. Will That Work?
FDA Announces Plan to Phase Out Animal Testing. Will That Work?
Human organs-on-chips and organoids offer new alternatives to animals for drug development, but there is still a long way to go.
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
FDA to review MSD’s doravirine/islatravir NDA for HIV-1
FDA to review MSD’s doravirine/islatravir NDA for HIV-1
FDA to review MSD’s doravirine/islatravir NDA for HIV-1
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand